Neuromuscular and Structural Effects of Using Stretching During the Recovery Phase Between Sets of Upper and Lower-body Strength Training
Efectos Neuromusculares y Estructurales de la utilización de Estiramientos en la Fase de recuperación Entre Series de Entrenamiento de la Fuerza de Los Miembros Superiores e Inferiores
Study Overview
Status
Conditions
Intervention / Treatment
- Other: Neuromuscular and structural effects of using AGONISTS stretching during the recovery phase between sets of upper and lower-body strength training
- Other: Neuromuscular and structural effects of using ANTAGONISTS stretching during the recovery phase between sets of upper and lower-body strength training
- Other: Neuromuscular and structural effects of using NOT stretching during the recovery phase between sets of upper and lower-body strength training
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Madrid
-
Villaviciosa de Odón, Madrid, Spain
- Edificio D
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Male or female adults aged 18-30 years. Apparently healthy, with no medical conditions that contraindicate participation in resistance training.
A minimum of 6 consecutive months of resistance training experience. Regular resistance training participation of at least three sessions per week during the previous 6 months.
Previous experience performing the back squat and bench press exercises with correct technique.
Ability to perform maximal intended concentric velocity during resistance exercises.
Willingness to refrain from vigorous physical activity during the 24 hours preceding each testing and training session.
Ability and willingness to comply with all study procedures. Provision of written informed consent.
Exclusion Criteria:
Current musculoskeletal injury affecting the upper or lower limbs that limits participation in resistance training or testing.
Acute or chronic pain that is aggravated by the study exercises. Cardiovascular, neurological, metabolic, or other medical conditions that contraindicate vigorous physical exercise.
Current participation in another structured intervention study or clinical trial.
Inability to attend the scheduled assessments or training sessions. Failure to comply with the study protocol or training requirements. Withdrawal of informed consent at any stage of the study. Occurrence of an adverse event during the intervention that prevents continued participation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Agonists stretching
Neuromuscular and structural effects of using AGONISTS stretching during the recovery phase between sets of upper and lower-body strength training
|
Neuromuscular and structural effects of using AGONISTS stretching during the recovery phase between sets of upper and lower-body strength training
Other Names:
|
|
Active Comparator: Antagonists stretching
Neuromuscular and structural effects of using ANTAGONISTS stretching during the recovery phase between sets of upper and lower-body strength training
|
Neuromuscular and structural effects of using ANTAGONISTS stretching during the recovery phase between sets of upper and lower-body strength training
Other Names:
|
|
Placebo Comparator: Control
Neuromuscular and structural effects of NOT using stretching during the recovery phase between sets of upper and lower-body strength training
|
Neuromuscular and structural effects of using NOT stretching during the recovery phase between sets of upper and lower-body strength training
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acute resistance-training performance: total number of repetitions
Time Frame: First intervention session (Week 1), across the four training sets.
|
Total number of repetitions completed across four sets of bench press and back squat during the first intervention session.
Participants will perform each set to momentary muscular failure at maximal intended concentric velocity, using individualized absolute loads corresponding to 75% of the estimated one-repetition maximum (1RM) for the bench press and 80% of the estimated 1RM for the back squat.
Repetitions completed in each set and total repetitions per exercise will be recorded to compare the immediate effects of agonist stretching, antagonist stretching, and no stretching.
|
First intervention session (Week 1), across the four training sets.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2024-495
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.